SCHEMBL149498

SCHEMBL149498

c1ccc2c(c1)[nH]c1c(CCN3CCOCC3)cccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
HPGD P15428 2/20 0.51
MAPT P10636 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HSD17B10 Q99714 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
TERT O14746 1/20 0.48
CCNE2 O96020 2/20 0.48
CDK4 P11802 2/20 0.48
CCND1 P24385 2/20 0.48
CCNE1 P24864 2/20 0.48
CDK2 P24941 2/20 0.48
CAMK2B Q13554 2/20 0.48
CAMK2G Q13555 2/20 0.48
CAMK2D Q13557 2/20 0.48
CAMK2A Q9UQM7 2/20 0.48
HTR2A P28223 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734052 0.76 HTR2A (0.76) HTR2ACYP2D6
SCHEMBL29992486 0.76 HTR2A (0.76) HTR2ACYP2D6
SCHEMBL30479087 0.75 SIGMAR1 (0.49) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL11577428 0.74 KIF11 (0.53) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL10670064 0.74 TSHR (0.54) ALDH1A1MAPTKDM4EHSD17B10KMT2A
Hydrochloric Acid SCHEMBL7381819 0.74 CYP2A13 (0.41) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL8776487 0.73 HTR1A (0.50) HTR2ATSHRPOLBSIGMAR1ABCB1
SCHEMBL7649096 0.73 HTR2A (0.78) HTR2AHTR2CCHRM3
SCHEMBL3462887 0.73 MAOB (0.51) ALDH1A1L3MBTL1HPGDMAPTKDM4E
SCHEMBL29291020 0.73 KIF11 (0.52) ALDH1A1HPGDMAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
US-8084620-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-12-27 US disclosed
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 ALDH1A1 3832/4885L3MBTL1 2214/4885HPGD 4175/4885
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 ALDH1A1 3832/4885L3MBTL1 2214/4885HPGD 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.